Be Ready to Prescribe Alternatives to Valsartan

The valsartan recall will continue to raise questions about how to switch to a different ARB or an ACE inhibitor.

The generic products impacted are a moving target. For now, the recall also includes some combos with hydrochlorothiazide or amlodipine.

The recalled products may have been contaminated with the probable carcinogen N-nitrosodimethylamine (NDMA) for as long as 4 years...possibly because of changes in how valsartan was made.

Get concise, unbiased advice for effective drug therapy, plus CE/CME

Prescriber's Letter includes:

  • 12 issues every year, with brief articles about new meds and guidelines
  • 48+ CE courses, including the popular CE-in-the-Letter
  • Quick reference drug comparison charts
  • Access to the entire archive

Already a subscriber? Log in

Volume pricing available. Get a quote